INBU mass layoffs

I've slept with the blonde otelza rep in my territory. she is nice on the outside but a freak in da sheets! aint no containing that!

 

Me too! She is sooooooo tasty! She's mmm mmm good!

 

My Otezla rep is killing it with dermatology, not so much with rheumatology. She is smoking hot. Model class.

 

You must be a Celgene rep. 30% PASi 75 is nothing to write home about. Less efficacious then Mtx @40%.

 

Not after this study:

The positive results came from an ongoing final-stage LIBERATE trial, a Phase IIIb randomized, placebo-controlled study aimed at evaluating the safety and effectiveness of Otezla in patients with moderate-to-severe plaque psoriasis. The study, with a total of 250 treatment-naïve patients, compared the effects on twice-daily 30 mg oral Otezla-treated patients, weekly 50 mg subcutaneous (SC) etanercept-treated patients, and placebo-treated patients at week 16. Otezla’s major competitor, Amgen, Inc.’s Enbrel, known by its chemical name etanercept, is an injectable drug commonly used to treat autoimmune diseases.

The study most significantly also attempted to evaluate the relative safety of switching etanercept-treated patients to Otezla after week 16.According to the results, at week 16, around 40% of the patients treated with Otezla 30 mg twice daily achieved a Psoriasis Area and Severity Index (PASI)-75 score — a 75% improvement in psoriasis — compared to 12% for patients given placebo.

In addition, the study revealed that a similar PASI-75 score was reached at week 16 by 48% of the patients treated with weekly injections of 50 mg etanercept, compared to 12% for placebo-treated patients. The study, however, was not designed to directly compare Otezla to Amgen’s Enbrel (etanercept).

 

Oh GREAT! Just what I need to see. My docs are writing this....

 

If you no longer work for Amgen, stop posting this stuff. We don't need your negativity.

 

As we have plenty of our own.

 

I am OBU and things are great. We are getting Kyprolis and Onyx reps will be fired when our DMs and RSD conspire to give them poor reviews and shitty accounts.

 

Exactly!!!

 

Top INBU white reps to move to Kyprolis as Onyx reps are leaving right and left!

 

This makes my day! I hate Onyx. They are so cocky and think they are special because they are oncology reps who came from Genentech. Don't they know how easy oncology is and that anyone can be an onc rep?

 

I am super pumped Amgen is taking over. Onyx couldn't sell water to a fish out of water in the desert if their lives depended on it.

 

Are some of us being transfered to Oncology? Sweet! I hope more Onyx reps leave then.

 

no, the company does not intend to keep you lazy good for nothing selling a 1000 year old product Enbrel reps--sorry but you are worthless to the OBU--and probably everywhere else in biotech

 

There is no need for any INBU white rep - Just get rid of them all - Worthless, Useless Saps of Doodoo

 

There is no need for OBU when Neulasta is generic and it's a contracting game!

 

Jeff Ludwig is talking to Daniel Billen about converting some INBU reps to Oncology to cover Kyprolis

 

Oncology can't see anyone. This model is dying. Most INBU reps will be transferred to GENMED division 2nd qtr 2016.